{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:08:02Z","timestamp":1784545682886,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"am","delay-in-days":278,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR065564"],"award-info":[{"award-number":["R01 AR065564"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bone.2021.115967","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T07:24:43Z","timestamp":1618989883000},"page":"115967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Osteocyte mechanosensing following short-term and long-term treatment with sclerostin antibody"],"prefix":"10.1016","volume":"149","author":[{"given":"Andrea E.","family":"Morrell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel T.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua Zhu","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gill","family":"Holdsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. Edward","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bone.2021.115967_bb0005","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jocd.2018.05.027","article-title":"Osteoporosis-related fracture events in the US","volume":"21","author":"Leader","year":"2018","journal-title":"Journal of Clinical Densitometry"},{"issue":"3","key":"10.1016\/j.bone.2021.115967_bb0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025","volume":"22","author":"Burge","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2021.115967_bb0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1210\/jc.2011-2332","article-title":"Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives","volume":"97","author":"Baron","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2021.115967_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00223-013-9790-y","article-title":"Osteocytes: master orchestrators of bone","volume":"94","author":"Schaffler","year":"2014","journal-title":"Calcif. Tissue Int."},{"issue":"13","key":"10.1016\/j.bone.2021.115967_bb0025","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","article-title":"Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation","volume":"19","author":"Poole","year":"2005","journal-title":"FASEB J."},{"issue":"23","key":"10.1016\/j.bone.2021.115967_bb0030","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.bone.2021.115967_bb0035","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist","volume":"199","author":"van Bezooijen","year":"2004","journal-title":"J. Exp. Med."},{"issue":"29","key":"10.1016\/j.bone.2021.115967_bb0040","doi-asserted-by":"crossref","first-page":"26770","DOI":"10.1074\/jbc.M504308200","article-title":"SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor","volume":"280","author":"Semenov","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.bone.2021.115967_bb0045","doi-asserted-by":"crossref","first-page":"26464","DOI":"10.1074\/jbc.M112.350108","article-title":"Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors","volume":"287","author":"Holdsworth","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.bone.2021.115967_bb0050","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bone.2021.115967_bb0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","article-title":"LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development","volume":"107","author":"Gong","year":"2001","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bone.2021.115967_bb0060","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","article-title":"Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation","volume":"8","author":"Glass","year":"2005","journal-title":"Dev. Cell"},{"issue":"3","key":"10.1016\/j.bone.2021.115967_bb0065","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.bone.2021.115967_bb0070","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.bone.2021.115967_bb0075","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1101\/gr.3437105","article-title":"Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease","volume":"15","author":"Loots","year":"2005","journal-title":"Genome Res."},{"issue":"2","key":"10.1016\/j.bone.2021.115967_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","article-title":"Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease","volume":"39","author":"Balemans","year":"2002","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/j.bone.2021.115967_bb0085","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/er.2011-1060","article-title":"Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases","volume":"33","author":"Ke","year":"2012","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.bone.2021.115967_bb0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2021.115967_bb0095","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.115967_bb0100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bone.2017.11.003","article-title":"Dampening of the bone formation response following repeat dosing with sclerostin antibody in mice is associated with up-regulation of Wnt antagonists","volume":"107","author":"Holdsworth","year":"2018","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2021.115967_bb0105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jcph.239","article-title":"Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: a randomized, double-blind, placebo-controlled study","volume":"54","author":"Padhi","year":"2014","journal-title":"J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.bone.2021.115967_bb0110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.bone.2021.115967_bb0115","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1210\/en.2013-1905","article-title":"Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody","volume":"155","author":"Li","year":"2014","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.bone.2021.115967_bb0120","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jbmr.1474","article-title":"Osteocytic network is more responsive in calcium signaling than osteoblastic network under fluid flow","volume":"27","author":"Lu","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2021.115967_bb0125","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.bone.2012.05.021","article-title":"Calcium response in osteocytic networks under steady and oscillatory fluid flow","volume":"51","author":"Lu","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.115967_bb0130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bone.2016.04.018","article-title":"T-type voltage-sensitive calcium channels mediate mechanically-induced intracellular calcium oscillations in osteocytes by regulating endoplasmic reticulum calcium dynamics","volume":"88","author":"Brown","year":"2016","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2021.115967_bb0135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bone.2013.01.008","article-title":"Spatiotemporal properties of intracellular calcium signaling in osteocytic and osteoblastic cell networks under fluid flow","volume":"53","author":"Jing","year":"2013","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2021.115967_bb0140","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1096\/fj.13-237578","article-title":"In situ intracellular calcium oscillations in osteocytes in intact mouse long bones under dynamic mechanical loading","volume":"28","author":"Jing","year":"2014","journal-title":"FASEB J."},{"issue":"44","key":"10.1016\/j.bone.2021.115967_bb0145","doi-asserted-by":"crossref","first-page":"11775","DOI":"10.1073\/pnas.1707863114","article-title":"Osteocyte calcium signals encode strain magnitude and loading frequency in vivo","volume":"114","author":"Lewis","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2021.115967_bb0150","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41413-018-0007-x","article-title":"Mechanically induced Ca(2+) oscillations in osteocytes release extracellular vesicles and enhance bone formation","volume":"6","author":"Morrell","year":"2018","journal-title":"Bone Res."},{"issue":"3\u20134","key":"10.1016\/j.bone.2021.115967_bb0155","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/03008207.2020.1712377","article-title":"Mechanosensitive Ca(2+) signaling and coordination is diminished in osteocytes of aged mice during ex vivo tibial loading","volume":"61","author":"Morrell","year":"2020","journal-title":"Connect. Tissue Res."},{"issue":"2","key":"10.1016\/j.bone.2021.115967_bb0160","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1530\/JME-18-0176","article-title":"Novel actions of sclerostin on bone","volume":"62","author":"Holdsworth","year":"2019","journal-title":"J. Mol. Endocrinol."},{"issue":"5","key":"10.1016\/j.bone.2021.115967_bb0165","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jbmr.3038","article-title":"Sclerostin antibody administration converts bone lining cells into active osteoblasts","volume":"32","author":"Kim","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"16","key":"10.1016\/j.bone.2021.115967_bb0170","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bone.2021.115967_bb0175","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jbmr.4193","article-title":"Mechanically driven counter-regulation of cortical bone formation in response to sclerostin-neutralizing antibodies","volume":"36","author":"Gerbaix","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.115967_bb0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bonr.2018.03.002","article-title":"Differential time-dependent transcriptional changes in the osteoblast lineage in cortical bone associated with sclerostin antibody treatment in ovariectomized rats","volume":"8","author":"Taylor","year":"2018","journal-title":"Bone Rep."},{"issue":"1","key":"10.1016\/j.bone.2021.115967_bb0185","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bone.2012.10.026","article-title":"Cortical and trabecular bone adaptation to incremental load magnitudes using the mouse tibial axial compression loading model","volume":"52","author":"Weatherholt","year":"2013","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bone.2021.115967_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130504","article-title":"Structural and mechanical improvements to bone are strain dependent with axial compression of the tibia in female C57BL\/6 mice","volume":"10","author":"Berman","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bone.2021.115967_bb0195","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1096\/fj.01-0913fje","article-title":"Genetic predisposition to low bone mass is paralleled by an enhanced sensitivity to signals anabolic to the skeleton","volume":"16","author":"Judex","year":"2002","journal-title":"FASEB J."},{"issue":"26","key":"10.1016\/j.bone.2021.115967_bb0200","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood-2017-03-773341","article-title":"Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma","volume":"129","author":"McDonald","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bone.2021.115967_bb0205","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2015.12.013","article-title":"Time-dependent cellular and transcriptional changes in the osteoblast lineage associated with sclerostin antibody treatment in ovariectomized rats","volume":"84","author":"Taylor","year":"2016","journal-title":"Bone"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221001290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221001290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:57:39Z","timestamp":1757613459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221001290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":41,"alternative-id":["S8756328221001290"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.115967","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteocyte mechanosensing following short-term and long-term treatment with sclerostin antibody","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.115967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115967"}}